Needham & Company Reiterates Nurix (NRIX) at Buy with $48 Price Target
Tweet Send to a Friend
Needham & Company analyst Gil Blum reiterated a Buy rating and $48.00 price target on Nurix (NASDAQ: NRIX), following a ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
